摘要
目的:观察60例急性心肌梗死(AMI)患者在发病早期应用前列地尔脂微球载体注射液(Lipo-PGE_1)治疗对QTc离散度(QTcd)的影响。方法:60例AMI患者随机分为前列地尔治疗组(n=31)和对照组(n=29)。治疗组在常规治疗基础上加用Lipo-PGE_1,疗程3周;对照组只采用常规治疗方法。记录每例患者入院后用药前和用药后第1,2,3,12,24 h和d3的12导联心电图测定QTcd。结果:入院后给药前测定QTcd治疗组与对照组间差异无显著性[(87.2±125)vs(86.9±11.3)ms,P>0.05],前壁与下壁梗死之间QTcd差异无显著性[(87.2±12.5)vs (86.7±12.1)ms,P>0.05]。治疗组在用Lipo-PGE_12 h时QTcd较对照组开始显著降低[(78.5±12.6)vs(87.8±13.6)ms,P<0.05],24h起QTcd较对照组极显著降低[(66.3±11.3)vs(88.1±13.2)ms,P<0.01]。治疗组有8例出现室性心律失常,在应用Lipo-PGE_12h后7例消失。结论:Lipo-PGE_1在AMI发病早期应用可降低QTcd,从而减少恶性心律失常发生,减少AMI的死亡率。
Objective : To evaluate the prophylaxis of QT intervals dispersions (QTcd) with alprostadil injections ( Lipo-PGE1 ) in patients with initial stage of acute myocardial infarction ( AMI ). Methods: 60 AMI inhospitalized patients were randomly treated with either conventional regimen (n = 29) or conventional regimen plus alprostadil injection (n = 31 ) for 3 weeks. The patients underwent a 12-lead ECG to monitor the QTcd pre-therapy and in 1, 2, 3, 12, 24 hours and day 3 post-therapy. Results: Compared to the conventional therapy of (87.8 ± 13.6) ms, the patients adding on PGE1 initiated the significant reduction of QTed in 2 hours post-therapy (78.5 ±12.6)ms. (P 〈 0.05 ). The QTcd of the patients injecting PGE1 was (66.3 ± 11.3) ms in 24 hours post-therapy, compared with the conventional therapy of (88.1± 13.2) ms (P 〈 0.01 ). The PGE1-treated patients experienced ventricular arrhythmias (8 out of 31 patients), of which 7 incidences were recovered when patients continued the PGE1 therapy for more than 2 hours. Conclusion: Administration of alprostadil at the early stage of AMI episode was beneficial in the reduction of the incidence of malignant arrhythmia and mortality due to AMI.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2006年第22期1969-1971,共3页
Chinese Journal of New Drugs
关键词
QTC离散度
心肌梗死
前列地尔脂微球载体注射液
QT intervals dispersions
acute myocardial infarction
alprostadil injection (Lipo-PGE1I )